Laguna Pharmaceuticals
Latest round
- Series B
Last raised
- Feb 2015
Total raised
- $32M
Investors
- 4
About Laguna Pharmaceuticals
, operates as a biopharmaceutical company that develops vanoxerine, a compound used to treat an increasingly common arrhythmia that can cause heart attacks and strokes called atrial fibrillation.
Who invested in Laguna Pharmaceuticals
4 investors across 2 rounds
See all investors in Laguna Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Laguna Pharmaceuticals
Who invested in Laguna Pharmaceuticals?
Laguna Pharmaceuticals has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Laguna Pharmaceuticals raised?
Laguna Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Laguna Pharmaceuticals last raise money?
Laguna Pharmaceuticals's most recent round on record is a Series B, in Feb 2015.
What does Laguna Pharmaceuticals do?
, operates as a biopharmaceutical company that develops vanoxerine, a compound used to treat an increasingly common arrhythmia that can cause heart attacks and strokes called atrial fibrillation.
Where is Laguna Pharmaceuticals headquartered?
Laguna Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Laguna Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Laguna Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Laguna Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.